Aurobindo Pharma Receives EIR for Sterile Drug Formulation Facility From U.S. FDA

Aurobindo Pharma Ltd is pleased to announce that it has received the Establishment Inspection Report (EIR) from the US FDA stating their acceptance on Aurobindo’s sterile injectable formulation facility in Chitkul Village, near Hyderabad, India.
Aurobindo